RENMAB

RenMab™ is designed to eliminate current bottlenecks faced during therapeutic antibody discovery. We envision it to be a leading platform that challenges the status quo and offers maximum potential to fill the unmet needs in discovering different antibody types and targets... The RenMab™ platform is an innovation resulting from the interdisciplinary collaboration between geneticists and immunologists within Biocytogen. Our scientific teams realized the current shortcomings in antibody discovery using transgenic animals in the current market landscape. As a result, the teams came together and worked hard to craft a better solution that will push the boundary of biomedical science... Biocytogen's RenMab™ and RenLite® humanized mice are powerful platforms for fully human therapeutic antibody discovery. The RenMab™ model, our best-in-class humanized antibody mouse, is ideal for the discovery of fully human therapeutic antibodies.

Primary location: Waltham United States